T

TransMedics Group
D

TMDX

71.869
USD
-3.59
(-4.76%)
مغلق
حجم التداول
43,895
الربح لكل سهم
1
العائد الربحي
-
P/E
77
حجم السوق
2,412,032,665
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    C
    CDNA
    -1.050
    (-4.50%)
    22.290 USD
    C
    CRSP
    -2.620
    (-5.19%)
    47.840 USD
    M
    MGTX
    0.45000
    (6.58%)
    7.29000 USD
    Q
    QURE
    -0.130
    (-1.00%)
    12.840 USD
    R
    RGNX
    -0.08500
    (-1.15%)
    7.28000 USD
    S
    SRPT
    -2.010
    (-1.86%)
    106.280 USD
    V
    VCEL
    -2.230
    (-4.11%)
    52.060 USD
    V
    VYGR
    -0.04000
    (-0.94%)
    4.22500 USD
    المزيد
الأخبار
المقالات

العنوان: TransMedics Group

القطاع: Healthcare
الصناعة: Medical Devices
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.